Scancell, Ltd.
P.O. Box 6457
Nottingham
NG5 1QA
United Kingdom
Tel: 44-0-115-962-8033
Fax: +44-0-115-962-8033
Website: http://www.scancell.co.uk/
Email: research@scancell.co.uk
52 articles about Scancell, Ltd.
-
Addario Lung Cancer Medical Institute And Scancell Form Partnership To Advance Lung Cancer Vaccine Clinical Trials
1/30/2017
-
Scancell Delays Melanoma Trial 9 to 12 Months to Whip Up New Batch of Cancer Vaccine
7/7/2016
-
Scancell Suspends Dosing in Melanoma Trial Due to Quality Issues
6/17/2016
-
SyndicateRoom Brings Crowd To £6.1 Million Fundraise For Cancer Treatment Company
4/1/2016
-
Scancell Release: Interim Results For The Six Months Ended 31 October 2015
1/27/2016
-
Scancell Release: Early Immune Effect Of SCIB1 Cancer Vaccine Observed In Blood By ImmunTraCkeR Companion Diagnostic
1/11/2016
-
Scancell Release: Directorate Change
1/7/2016
-
Scancell Release: Key Moditope Paper Published In Cancer Research
1/5/2016
-
Scancell To Conduct Phase II Checkpoint Inhibitor Combination Study With SCIB1 With Leading Us Melanoma Specialists
12/18/2015
-
Scancell: Translating Innovative Science Into Ground-Breaking New Products
10/20/2015
-
Scancell Strengthens Operational And Clinical Development Expertise
10/14/2015
-
Scancell Release: Six Scientific Presentations At The Progress In Vaccination Against Cancer Conference Highlight Potential Of Immunobody And Moditope Platform Technologies
10/6/2015
-
Scancell Final Results For The Year Ended 30 April 2015
9/18/2015
-
Scancell’s Immunobody Platform Being Presented At The Cancer Vaccines Conference, London
9/16/2015
-
Scancell And Immunid Announce Collaboration To Predict SCIB1 Responders Using Immuntracker
7/30/2015
-
Scancell Patient Recruitment Completed For SCIB1 Phase 1/2 Clinical Trial
7/9/2015
-
ASCO15: Scancell Provides Positive Update On SCIB1 Data In Resected Melanoma Patients
6/2/2015
-
Scancell To Provide Update On SCIB1 Data In Resected Melanoma Patients At 2015 ASCO Annual Meeting
5/18/2015
-
Scancell To Provide Positive SCIB1 Phase 1/2 Clinical Trial Update During Corporate Presentations 12-15 January, San Francisco
1/12/2015
-
Scancell Release: AGM Research And Development Update Highlights Progress In Both SCIB1 Clinical Trial And Moditope® Platform
10/14/2014